Loading...
XSHG
688622
, Last price  
Name

Guangzhou Hexin Instrument Co Ltd

Chart & performance

D1W1MN
XSHG:688622 chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
5.93%
Rev. 5Y
-20.52%
Div Yld LY
—
Div Yld TTM
—
Revenues
99m
-51.08%
71,025,97791,785,522102,569,491124,725,650219,837,151312,272,106464,237,256280,256,751366,178,969202,509,09799,066,435
Net income
-95m
L+106.13%
10,001,98215,944,24820,502,41920,035,15346,474,28469,453,96178,574,751-63,328,254-96,106,048-45,990,939-94,801,752
CFO
9m
34,239,46618,039,01804,922,57077,901,18064,087,11614,928,8990-36,367,27009,220,348
Dividend
Jun 15, 20220.17 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangzhou Hexin Instrument Co.,Ltd. specializes in the development and production of mass spectrometry (MS) instruments, alongside offering comprehensive testing services. Their diverse product portfolio addresses various applications. For environmental monitoring, they provide advanced systems such as online mass spectrometers for volatile organic compound (VOC) analysis, PM2.5 online source apportionment and monitoring systems, online pre-concentrator gas chromatography MS monitoring systems, two-dimensional gas chromatography time-of-flight MS, and portable VOC analysis MS devices. In the biomedical sector, their offerings include automated microbial MS detection systems. Laboratory-focused instruments feature inductively coupled plasma MS, automatic microbial MS detection systems, two-dimensional gas chromatography time-of-flight MS, and liquid chromatography-time-of-flight MS. Established in 2004, the company is headquartered in Guangzhou, China.
IPO date
Sep 13, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT